Bruno Eschli

Bruno Eschli is the Head of Investor Relations at Roche, serving since August 2014 and is a member of the Executive Leadership Team and the ESG steering committee. Prior experience includes roles as an Investor Relations Officer at Bank am Bellevue AG from January 2008 to July 2014, where responsibilities included heading the Pharma/Biotech sell-side Research Team and serving as an equity analyst. In 2007, Bruno Eschli contributed to the Global and German Biotech Reports at Ernst & Young's European Life Science Center and completed a postdoctoral fellowship in immunology at UniversitätsSpital Zürich under Nobel laureates. Educational qualifications include a Dr. sc. from ETH Zürich in Biochemistry, Immunology, and Virology, along with various degrees and internships from prestigious institutions such as London Business School and The Rockefeller University.